ERAnet EURONANOMED - ERAnet EURONANOMED : Appel à projets transnational sur la nanomédecine 2009

Photo Dynamic Therapy using photosensitizer-doped targeted organic nanoparticle – TARGET-PDT

Submission summary

Photodynamic therapy (PDT) is an emerging modality for the treatment of various cancers. PDT consists of a photoactive drug known as a photosensitizer, its preferential uptake and retention in malignant tissues, and its subsequent activation by a visible laser light, leading to tumor destruction. Despite its many advantages, the use of PDT has been restrained due to ineffective targeting of the photosensitizers to the tumor and potential damage to nearby healthy cells. Therefore, the project will study the delivery of photosensitizers encapsulated into lipid nano-particles that will include tumor-specific antibodies, thereby improving targeting and minimizing destruction of healthy tissue.

Project coordination

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

Help of the ANR 546,230 euros
Beginning and duration of the scientific project: - 0 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter